Brief: Adial Pharmaceuticals Inc Files With SEC For Resale Of Up To 10.2 Mln Common Shares By Alumni Capital LP
June 23 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 10.2
MILLION
COMMON SHARES BY ALUMNI CAPITAL LP - SEC FILING
Source text for Eikon: [http://bitly.ws/Jnw6]
Further company coverage: ADIL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)